Lionheart Longevity News
Lionheart Health Announces Positive Clinical Study Results for BodStim™
Lionheart Health Announces Positive Clinical Study Results for BodStim™ Demonstrates Measurable Gains in Strength, Mobility, Muscle Mass, and Longevity Biomarkers…
Leonhardt Ventures Unveils RegenaLung™ Klotho-Expressing Stem Cell Inhaler for Lung Regeneration
Leonhardt Ventures Unveils RegenaLung™ Klotho-Expressing Stem Cell Inhaler for Lung Regeneration; Licenses Technology to Lionheart Health Innovative inhalable therapy combines…
Lionheart Health Announces Breakthrough in Bioelectric Activation of 15-PGDH for Osteoarthritis and Inflammatory Diseases
Huntington Beach, CA — April 23rd, 2026 Lionheart Health, Inc. today announced the filing of a provisional patent application covering a novel…Lionheart Octopus™ by Lionheart Health, Inc. Wins UCI Capstone Engineering Award
University of California, Irvine Student Engineering Team to Advance Next-Generation Implantable Regenerative Platform (April–December 2026) Irvine, CA — April 25th…
Lionheart Health Announces Positive Clinical Results for OrthoStim™ Bioelectric Therapy and Launches Next-Generation Comprehensive Joint Health Protocol for Knee Osteoarthritis
Huntington Beach, California — April 23, 2026 — Lionheart Health today announced strong clinical outcomes from its OrthoStim™ bioelectric therapy program for knee osteoarthritis, alongside…
Lionheart Health Launches Telomere & Mitochondrial Satellite Arm to Klotho-Up™ Study
Huntington Beach, California — April 20, 2026 — Lionheart Health, Inc., a leader in bioelectric regenerative medicine and healthspan optimization, today…
Lionheart Health Launches Bioelectric Therapy Platform to Prevent Aneurysm Progression
Huntington Beach, California — April 16, 2026 — Leonhardt Ventures LLC and licensee Lionheart Health, Inc. today announced the development of a groundbreaking…